Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis
Clinical trial NCT03148756 · TERMINATED
Trial details
- NCT number
- NCT03148756
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-12
- Primary completion
- 2017-08-04
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.